Robert W. Weber
California Institute of Technology · 105 works · 16,849 citations · h-index 21
Top works
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- Kinetics of response to ipilimumab (MDX-010) in patients with stage III/IV melanoma
- .beta.-Carbolines: synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors
- La lettre grecque K employée comme signe de correction dans les manuscrits bibliques latins écrits « per cola et commata »
- COMPLICATIONS OF INFECTIOUS MONONUCLEOSIS
- Die Reste der altlateinischen Bibel, 2
- Phase II, Randomized, Controlled, Double-Blinded Trial of Weekly Elesclomol Plus Paclitaxel Versus Paclitaxel Alone for Stage IV Metastatic Melanoma
- A phase III, randomized, double-blind, multicenter study comparing monotherapy with ipilimumab or gp100 peptide vaccine and the combination in patients with previously treated, unresectable stage III or IV melanoma.
- The Infrared Imaging Spectrograph (IRIS) for TMT: instrument overview
- General Approach for the Synthesis of Ajmaline/Sarpagine Indole Alkaloids: Enantiospecific Total Synthesis of (+)-Ajmaline, Alkaloid G, and Norsuaveoline via the Asymmetric Pictet−Spengler Reaction
- Structural features of the quinidine and quinine molecules necessary for binding of drug-induced antibodies to human platelets.
- 7005 ORAL Ipilimumab (MDX-010) in patients with stage III/IV melanoma: kinetics and duration of response
- 3-Hydroxymethyl-β-carboline antagonizes some pharmacologic actions of diazepam
- A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma
- General method for the synthesis of [n.3.3]propellanes, n ≥ 3
- Enhanced kidney clearance with an ester-linked 99mTc-radiolabeled antibody Fab'-chelator conjugate
- Halogenation of 1,6-diazaphenalene. Theoretical and experimental results
- Stereospecific synthesis of -1,3-disubstituted-1,2,3,4-tetrahydro β-carbolines
- Recombinant Human Granulocyte-macrophage Colony-stimulating Factor (GM-CSF, Sargramostim) Administered for 3 Years as Adjuvant Therapy of Stages II(T4), III, and IV Melanoma
- Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomised trial in 220 patients with colorectal cancer